Literature DB >> 6313153

The interactive effects of fluoride and N-formyl-L-methionyl-L-leucyl-L-phenylalanine on superoxide production and cAMP levels in human neutrophils.

K Wong.   

Abstract

The kinetics of superoxide (O2-) production and intracellular cAMP levels were monitored in human neutrophils incubated in vitro with sodium fluoride and the chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP). F- activation of both the O2- -generating system, NAD(P)H oxidase, and adenylate cyclase was characterized by a prolonged lag period of 8 to 10 min at 37 degrees C. Adenylate cyclase agonists or cAMP analogues which inhibited FMLP-induced O2- bursts did not affect O2- production of F- -activated cells. Prior treatment of cells with F- suppressed the short rapid burst elicited by FMLP but not the binding of the tripeptide. FMLP reciprocally decreased the lag period of the F- -induced burst by 40 to 50% and, in the case of cells incubated at temperatures below 37 degrees C, increased the rate of O2- production. A similar potentiating effect of FMLP on F- -induced elevation of intracellular cAMP levels was observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313153     DOI: 10.1139/o83-073

Source DB:  PubMed          Journal:  Can J Biochem Cell Biol        ISSN: 0714-7511


  3 in total

1.  Dual regulation of neutrophil adenylate cyclase by fluoride and its relationship to cellular activation.

Authors:  M Saad; C F Strnad; K Wong
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

2.  Fluoride activation of neutrophils: similarities to formylmethionyl-leucyl-phenylalanine.

Authors:  W L Gabler; H R Creamer; W W Bullock
Journal:  Inflammation       Date:  1989-02       Impact factor: 4.092

3.  Effect of sodium fluoride on the generation of lipoxygenase products from human polymorphonuclear granulocytes, mononuclear cells and platelets--indication for the involvement of G proteins.

Authors:  C Brom; M Köller; J Brom; W König
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.